Media ReleasesNext Science

View All Next Science News


Next Science - Irrimax complaint


Next Science Limited (ASX:NXS) (Next Science / Company) advises that Irrimax Corporation has filed a complaint in the United States District Court for the Northern District of Georgia alleging common law unfair competition and false advertising regarding XPerience.

Next Science is a new entrant in the surgery irrigation market with XPerience, a FDA cleared no rinse antimicrobial solution. Next Science has independent third party data showing the performance of XPerience compared with other in-market surgery irrigation products. Irrimax Corporation is a supplier of a chlorhexidine wash (99.95% water 0.05% chlorhexidine) into the surgery irrigation market.

For more information, download the attached PDF.

Download this document

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?